Quantcast

Latest pharmaceutical industry Stories

2014-08-31 23:03:49

Datex Pharmaceutical Software now includes a suite of features which enables compliance of the new FDA regulation, the Drug Quality Security Act (DQSA). Clearwater FL (PRWEB) August 31, 2014 Datex Pharmaceutical Software now includes a suite of features which enables compliance of the new FDA regulation, the Drug Quality Security Act (DQSA). The FDA Drug Quality and Security Act (DQSA) was signed into law in late 2013. Established to address threats to patient safety and security, the...

2014-08-30 23:00:40

In light of the latest development in Actos litigation, The Law Office of Melinda J. Helbock A.P.C. announces that it continues to investigate potential lawsuits on behalf of Actos users who have been diagnosed with bladder cancer. San Diego, CA (PRWEB) August 30, 2014 According to Bloomberg, U.S. District Judge Rebecca Doherty upheld a decision that requires Takeda Pharmaceutical Co. and Eli Lilly & Co. to pay $9 billion in punitive damages for claims that the drugmakers concealed...

2014-08-29 23:09:19

Clinical Trial Magnifier Weekly monitors 150,000 trials in 185 countries around the world every week and reports all the fresh changes. By sifting through tens of thousands of records, FDAnews is able to extract just the information readers need. Falls Church, VA (PRWEB) August 29, 2014 http://www.fdanews.com/CTMPR FDAnews is proud to announce the release of Clinical Trials Magnifier Weekly. Clinical Trial Magnifier Weekly monitors 150,000 trials in 185 countries around the world every...

2014-08-29 12:25:02

DUBLIN, Aug. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 mainly analyzes China's pharmaceutical equipment industry in the aspects of current market status, supply & demand, competition...

2014-08-29 08:24:27

Investor update call to be held Tuesday, September 2 VANCOUVER, British Columbia and MENLO PARK, Calif., Aug. 29, 2014 /PR Newswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing of June 30, 2014 fiscal year-end financial statements. The Company recently changed its fiscal year end to June 30th in order to facilitate an application to list its common stock on a national securities exchange in the timeliest manner possible. DelMar's...

2014-08-28 23:10:26

The NAPSRX has received a small grant and awarded the 2014 Kennedy Educational Award in Washington, D.C. to support the future establishment and implementation of advanced Pharmaceutical Sales Vocational Education. Washington, DC (PRWEB) August 28, 2014 The NAPSRx announced today that it has received a small grant and awarded the 2014 Kennedy Educational Award in Washington, D.C. to support the future establishment and implementation of advanced Pharmaceutical Sales Vocational Educational...

2014-08-28 12:30:58

RnRMarketResearch.com adds "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland" & "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey" to its store. DALLAS, Aug. 28, 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland (Photo - http://photos.prnewswire.com/prnh/20140828/140879) The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Poland" an essential source of information and...

2014-08-28 12:30:53

DENVER, Aug. 28, 2014 /PRNewswire/ -- Pharmatech initiated enrollment for its AccessPPM program after a two-year investment into this game-changing method for matching cancer patients to cancer clinical trials. Today, clinical trials target specific cancers, disease staging, and genetic mutations - which may be contributing factors for the cancer, in the first place. The challenge that the industry faces, is that this information may not be well known to the patient or even their...

2014-08-28 12:30:38

CHENGDU, China, Aug. 28, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today updates the timeline for the GMP certification regarding the Company's Qionglai Facility (QLF). The Company is scheduled to submit the Good Manufacturing Practice (GMP) dataset for China Food &...

2014-08-28 12:29:56

PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration (FDA). This product is the generic version of Teva's Copaxone® 40 mg/mL, which is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS)....


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'